Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Caccuri

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
Clinical Immunology (Orlando, Fla.)|February 18, 2021
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohortFrancesca Caccuri, Antonella Bugatti, Antonella Meini, et al.
Journal of Virology|March 14, 2014
Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growthFrancesca Caccuri, Cinzia Giagulli, Joachim Reichelt, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 7, 2018
Fulminant septic shock caused by Capnocytophaga canimorsus in Italy: Case reportGiorgio Piccinelli, Francesca Caccuri, Elena De Peri, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
A Dynamic and Effective Peptide-Based Strategy for Promptly Addressing Emerging SARS-CoV-2 Variants of ConcernMichela Murdocca, Isabella Romeo, Gennaro Citro, et al.
AIDS (London, England)|August 15, 2014
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activityCinzia Giagulli, Francesca Caccuri, Francesca Cignarella, et al.
The Journal of Biological Chemistry|November 21, 2012
Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonistsAntonella Bugatti, Cinzia Giagulli, Chiara Urbinati, et al.
ACS Applied Materials & Interfaces|November 9, 2021
Transparent Polymeric Formulations Effective against SARS-CoV-2 InfectionValentina Gentili, Daniele Pazzi, Sabrina Rizzo, et al.
Vaccine|January 25, 2014
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity studyMaria Luisa Iaria, Simona Fiorentini, Emanuele Focà, et al.
International Journal of Molecular Sciences|March 20, 2020
Role of Autophagy in Von Willebrand Factor Secretion by Endothelial Cells and in the In Vivo Thrombin-Antithrombin Complex Formation Promoted by the HIV-1 Matrix Protein p17Antonella Bugatti, Stefania Marsico, Pietro Mazzuca, et al.
Viruses|June 26, 2026
Report from the 9th Italian Society for Virology (SIV-ISV) 2025 Annual MeetingAnna De Filippis, Manuela Donalisio, Anna Luganini, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Clinical Immunology (Orlando, Fla.)|February 18, 2021
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohortFrancesca Caccuri, Antonella Bugatti, Antonella Meini, et al.
Journal of Virology|March 14, 2014
Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growthFrancesca Caccuri, Cinzia Giagulli, Joachim Reichelt, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 7, 2018
Fulminant septic shock caused by Capnocytophaga canimorsus in Italy: Case reportGiorgio Piccinelli, Francesca Caccuri, Elena De Peri, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
A Dynamic and Effective Peptide-Based Strategy for Promptly Addressing Emerging SARS-CoV-2 Variants of ConcernMichela Murdocca, Isabella Romeo, Gennaro Citro, et al.
AIDS (London, England)|August 15, 2014
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activityCinzia Giagulli, Francesca Caccuri, Francesca Cignarella, et al.
The Journal of Biological Chemistry|November 21, 2012
Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonistsAntonella Bugatti, Cinzia Giagulli, Chiara Urbinati, et al.
ACS Applied Materials & Interfaces|November 9, 2021
Transparent Polymeric Formulations Effective against SARS-CoV-2 InfectionValentina Gentili, Daniele Pazzi, Sabrina Rizzo, et al.
Vaccine|January 25, 2014
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity studyMaria Luisa Iaria, Simona Fiorentini, Emanuele Focà, et al.
International Journal of Molecular Sciences|March 20, 2020
Role of Autophagy in Von Willebrand Factor Secretion by Endothelial Cells and in the In Vivo Thrombin-Antithrombin Complex Formation Promoted by the HIV-1 Matrix Protein p17Antonella Bugatti, Stefania Marsico, Pietro Mazzuca, et al.
Viruses|June 26, 2026
Report from the 9th Italian Society for Virology (SIV-ISV) 2025 Annual MeetingAnna De Filippis, Manuela Donalisio, Anna Luganini, et al.
Pageof 13